NCT03752463View on ClinicalTrials.gov

NMDA Enhancer for the Treatment of Mild Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

May 22, 2015

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Alzheimer Disease
Interventions
DRUG

DAOI-A group

DAOI with A dose

DRUG

DAOI-B group

DAOI with B dose

DRUG

DAOI-C group

DAOI with C dose

DRUG

Placebo oral capsule

Placebo

Trial Locations (1)

886

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Ministry of Science and Technology, Taiwan

OTHER_GOV

lead

Chang Gung Memorial Hospital

OTHER

NCT03752463 - NMDA Enhancer for the Treatment of Mild Alzheimer's Disease | Biotech Hunter | Biotech Hunter